Protocols For Health, ALA CR 60 Tablets
Controlled-Release Alpha-Lipoic Acid
ALA CR is a whole-body, multifunctional antioxidant that helps to maintain healthy, well-functioning cells. ALA CR is designed to neutralize free radicals. ALA CR has the ability to destroy free radicals in both the water-based and lipid-based portions of cells, making it the ideal whole-body antioxidant. In addition, ALA CR helps the body synthesize glutathione, the body’s own master detoxifier. ALA CR also “recharges” other important antioxidants, such as vitamins C and E, and CoQ10, giving them the ability to continue fighting free radicals for extended periods of time. In addition, biotin supports the function of alpha-lipoic acid in regulating glucose metabolism.*
- Provides Fat-Soluble and Water-Soluble Antioxidant Activity*
- Coenzyme for Whole-Body Glucose Utilization*
- Supports Healthy Intracellular Glutathione Levels*
- Supports Regeneration of Vitamins C and E*
- Helps Maintain a Balance Between Oxidized and Reduced CoQ10*
Hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, hydroxypropyl cellulose, dicalcium phosphate, silica, and coating (hydroxypropyl methylcellulose and medium-chain triglycerides).
Take one tablet 30 minutes before breakfast and one tablet 30 minutes before dinner, or as directed by your healthcare professional. Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professionals. Do not use it if the tamper seal is damaged.
Keep closed in a cool, dry place out of reach of children.
Formulated To Exclude:
Wheat, gluten, yeast, corn, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, eggs, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.